HRT FINANCIAL LP

Position in CRSP — CRISPR Therapeutics AG

CIK 1475597 NEW YORK, NY

Position in CRSP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,344,574

+$3,989,367 QoQ

Shares Held

134,664

+90.9% QoQ

Ownership

0.139%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#54

of 521 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names. CRSP ranks #29 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,344,574	134,664	+90.9%	Shares	Defined	2026-08-14
2026-03-31	$3,355,207	70,532	+152.2%	Shares	Defined	2026-05-14
2025-12-31	$1,466,851	27,972	-69.2%	Shares	Defined	2026-02-12
2025-03-31	$3,093,837	90,915	+952.5%	Shares	Defined	2025-05-15
2024-12-31	$339,991	8,638	-87.6%	Shares	Defined	2025-02-14
2024-03-31	$4,732,280	69,429	+392.6%	Shares	Defined	2024-05-13
2023-06-30	$791,181	14,093	-60.3%	Shares	Defined	2023-08-11
2023-03-31	$1,604,941	35,484	+151.9%	Shares	Defined	2023-05-12
2022-12-31	$572,514	14,084	-86.2%	Shares	Defined	2023-02-10
2021-06-30	$16,469,231	101,731	+868.0%	Shares	Defined	2021-08-16
2021-03-31	$1,280,521	10,509	+179.0%	Shares	Defined	2021-05-17
2020-06-30	$276,763	3,766	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.